342 related articles for article (PubMed ID: 29160839)
1. Inkjet Printing of Drug-Loaded Mesoporous Silica Nanoparticles-A Platform for Drug Development.
Wickström H; Hilgert E; Nyman JO; Desai D; Şen Karaman D; de Beer T; Sandler N; Rosenholm JM
Molecules; 2017 Nov; 22(11):. PubMed ID: 29160839
[TBL] [Abstract][Full Text] [Related]
2. Carboxyl-functionalized mesoporous silica nanoparticles for the controlled delivery of poorly water-soluble non-steroidal anti-inflammatory drugs.
Gou K; Wang Y; Guo X; Wang Y; Bian Y; Zhao H; Guo Y; Pang Y; Xie L; Li S; Li H
Acta Biomater; 2021 Oct; 134():576-592. PubMed ID: 34280558
[TBL] [Abstract][Full Text] [Related]
3. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
Yan Y; Fu J; Wang T; Lu X
Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
[TBL] [Abstract][Full Text] [Related]
4. Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.
She X; Chen L; Yi Z; Li C; He C; Feng C; Wang T; Shigdar S; Duan W; Kong L
Mini Rev Med Chem; 2018; 18(11):976-989. PubMed ID: 27145854
[TBL] [Abstract][Full Text] [Related]
5. Applications of mesoporous materials as excipients for innovative drug delivery and formulation.
Shen SC; Ng WK; Chia LS; Dong YC; Tan RB
Curr Pharm Des; 2013; 19(35):6270-89. PubMed ID: 23470004
[TBL] [Abstract][Full Text] [Related]
6. Combining inkjet printing and amorphous nanonization to prepare personalized dosage forms of poorly-soluble drugs.
Cheow WS; Kiew TY; Hadinoto K
Eur J Pharm Biopharm; 2015 Oct; 96():314-21. PubMed ID: 26325060
[TBL] [Abstract][Full Text] [Related]
7. Mesoporous Silica Platforms with Potential Applications in Release and Adsorption of Active Agents.
Chircov C; Spoială A; Păun C; Crăciun L; Ficai D; Ficai A; Andronescu E; Turculeƫ ȘC
Molecules; 2020 Aug; 25(17):. PubMed ID: 32825791
[TBL] [Abstract][Full Text] [Related]
8. Exploring the role of mesoporous silica nanoparticle in the development of novel drug delivery systems.
Stephen S; Gorain B; Choudhury H; Chatterjee B
Drug Deliv Transl Res; 2022 Jan; 12(1):105-123. PubMed ID: 33604837
[TBL] [Abstract][Full Text] [Related]
9. Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cells.
Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Xue M; Amin M; Shahtahmassebi N; Malaekeh-Nikouei B
Eur J Pharm Biopharm; 2015 Jan; 89():248-58. PubMed ID: 25511563
[TBL] [Abstract][Full Text] [Related]
10. Inkjet printing of drug substances and use of porous substrates-towards individualized dosing.
Sandler N; Määttänen A; Ihalainen P; Kronberg L; Meierjohann A; Viitala T; Peltonen J
J Pharm Sci; 2011 Aug; 100(8):3386-3395. PubMed ID: 21360709
[TBL] [Abstract][Full Text] [Related]
11. Modified mesoporous silica nanoparticles for enhancing oral bioavailability and antihypertensive activity of poorly water soluble valsartan.
Biswas N
Eur J Pharm Sci; 2017 Mar; 99():152-160. PubMed ID: 27993684
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of different substrates for inkjet printing of rasagiline mesylate.
Genina N; Janßen EM; Breitenbach A; Breitkreutz J; Sandler N
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1075-83. PubMed ID: 23563101
[TBL] [Abstract][Full Text] [Related]
13. Mesoporous silica nanoparticle-supported nanocarriers with enhanced drug loading, encapsulation stability, and targeting efficiency.
Oh JY; Yang G; Choi E; Ryu JH
Biomater Sci; 2022 Mar; 10(6):1448-1455. PubMed ID: 35229845
[TBL] [Abstract][Full Text] [Related]
14. Mesoporous Silica Molecular Sieve based Nanocarriers: Transpiring Drug Dissolution Research.
Pattnaik S; Pathak K
Curr Pharm Des; 2017; 23(3):467-480. PubMed ID: 27784249
[TBL] [Abstract][Full Text] [Related]
15. Ionic and thermo-switchable polymer-masked mesoporous silica drug-nanocarrier: High drug loading capacity at 10°C and fast drug release completion at 40°C.
Eltohamy M; Seo JW; Hwang JY; Jang WC; Kim HW; Shin US
Colloids Surf B Biointerfaces; 2016 Aug; 144():229-237. PubMed ID: 27092438
[TBL] [Abstract][Full Text] [Related]
16. Successfully tailoring the pore size of mesoporous silica nanoparticles: exploitation of delivery systems for poorly water-soluble drugs.
Jia L; Shen J; Li Z; Zhang D; Zhang Q; Duan C; Liu G; Zheng D; Liu Y; Tian X
Int J Pharm; 2012 Dec; 439(1-2):81-91. PubMed ID: 23078857
[TBL] [Abstract][Full Text] [Related]
17. Mesoporous silica nanoparticles as nanocarriers.
Wu SH; Hung Y; Mou CY
Chem Commun (Camb); 2011 Sep; 47(36):9972-85. PubMed ID: 21716992
[TBL] [Abstract][Full Text] [Related]
18. Targeting of Thymoquinone-loaded mesoporous silica nanoparticles to different brain areas: In vivo study.
Fahmy HM; Fathy MM; Abd-Elbadia RA; Elshemey WM
Life Sci; 2019 Apr; 222():94-102. PubMed ID: 30826496
[TBL] [Abstract][Full Text] [Related]
19. Tailor-made pH-sensitive polyacrylic acid functionalized mesoporous silica nanoparticles for efficient and controlled delivery of anti-cancer drug Etoposide.
Saroj S; Rajput SJ
Drug Dev Ind Pharm; 2018 Jul; 44(7):1198-1211. PubMed ID: 29412022
[TBL] [Abstract][Full Text] [Related]
20. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
